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Background
Systemic Juvenile Idiopathic Arthritis (SJIA) is heteroge-
neous in severity, course and outcome. Predictive factors
for a poor outcome include persistent systemic features
(fever, thrombocytosis) and younger age at onset.
Aim
To describe and analyze the disease features in patients
with SJIA with very early onset and to compare them
with those of patients with later onset.
Methods
Retrospective analysis of clinical data. Early-onset (EO)
was defined as the start of SJIA prior to age 18 months.
Variables included: demographic and clinical features at
onset and outcome variables during disease course (pat-
tern of course, presence of clinical joint damage [using
the Juvenile Arthritis Damage Index or JADI], radio-
graphic joint damage [erosions], destructive hip disease,
disability [CHAQ > 0.5], growth retardation, develop-
ment of macrophage activation syndrome [MAS], need
for biologic agents, and death). Patients with EO were
compared with patients with disease onset at age ≥ 18
months. Chi square and Mann-Whitney tests were used
for comparisons.
Results
192 patients (115 girls, 23 EO) followed between 1995
and 2010 were included. Age at onset was 12 (2-17)
months in patients with EO, 72 (18-191) months in
patients with non-EO. Delay in diagnosis (2 months)
and duration of follow-up (10 vs 8 years) were similar in
both groups. Eight patients (1 EO, 7 non-EO) died dur-
ing the observation period. Patients with EO showed
more frequently serositis (p=0.0003), hepatomegaly
(p=0.01), splenomegaly (p=0.03), lower number of active
joints (p=0.01), Hgb (p=0.02), and higher plt (p=0.04) at
onset; more frequently MAS (p=0.0001), therapy with
biologics (p=0.01), destructive hip disease (p=0.04),
radiographic damage (p=0.01), growth retardation
(p=0.05), disability (p=0.01), and higher JADI score
(p=0.003).
Conclusions
Patients with SJIA starting before age 18 months show
more systemic inflammatory features, and a poorer out-
come than children with later disease onset. They may
represent a distinct subset. This observation should
prompt rheumatologists to initiate early aggressive ther-
apy and close follow-up in this age group.
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